Extrahepatic manifestations of hepatitis B infection

Viral Hepatitis: Fourth Edition

Volumn , Issue , 2013, Pages 154-162

  Trépo, Christian ^a,b   Amiri, Majid ^a,b   Guillevin, Loïc ^c  

^a CROIX ROUSSE HOSPITAL   (France)

^b CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^c Institut Cochin   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84987693001     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118637272.ch11     Document Type: Chapter

References (63)

1. Merle P, Trepo C. Therapeutic management of hepatitis B related cirrhosis. J Viral Hepat 2001;6:391-399.
2. Trepo C, Guillevin L. Polyarteritis nodosa and extrahepatic manifestations of HBV infection: the case against autoimmune intervention in pathogenesis. J Autoimmun 2001;16:269-274.
3. Wartelle-Bladou C, Lafon J, Trepo C, et al. Successful combination therapy of polyarteritis nodosa associated with a pre-core promoter mutant hepatitis B virus infection. J Hepatol 2001;34:774-779.
4. Trepo C, Thivolet J. Antigène Australia, virus de l'hépatite et périartérite noueuse. Presse Med 1970;78:1575.
5. Trepo C, Thivolet J. Hepatitis associated antigen and periarteritis nodosa (PAN). Vox Sang 1970;19:410-411.
6. Gocke DJ, Hsu K, Morgan C, Bombardieri S, Lockshin M, Christian CL. Vasculitis in association with Australia antigen. J Exp Med 1971;134:330s-336s.
7. Scott DG, Bacon PA, Elliott PJ, Tribe CR, Wallington TB. Systemic vasculitis in a district general hospital 1972-1980: clinical and laboratory features, classification and prognosis of 80 cases. QJM 1982;51:292-311.
8. McMahon BJ, Bender TR, Templin DW, et al. Vasculitis in Eskimos living in an area hyperendemic for hepatitis B. JAMA 1980;244:2180-2182.
9. Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R, et al. No difference in the incidences of vasculitides between north and south Germany: first results of the German vasculitis register. Rheumatology (Oxford) 2002;41:540-549.
10. Mahr A, Guillevin L, Poissonnet M, Ayme S. Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener' s granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis Rheum 2004;51:92-99.
11. Guillevin L, Mahr A, Callard P, et al. Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients. Medicine (Baltimore) 2005; 84:313-322.
12. Mason A, Theal J, Bain V, et al. Hepatitis B virus replication in damaged endothelial tissues of patients with extrahepatic disease: a case report. Am J Gastroenterol 2005;100:972-976.
13. Moore PM, Calabrese LH. Neurologic manifestations of systemic vasculitides. Semin Neurol 1994;14:300-306.
14. Camilleri M, Pusey CD, Chadwick VS, Rees AJ. Gastrointestinal manifestations of systemic vasculitis. QJM 1983;52:141-149.15. Pagnoux C, Mahr A, Cohen P, Guillevin L. Presentation and outcome of gastrointestinal involvement in systemic necrotizing vasculitides: analysis of 62 patients with polyarteritis nodosa, microscopic polyangiitis, Wegener granulomatosis, Churg-Strauss syndrome, or rheumatoid arthritis-associated vasculitis. Medicine (Baltimore) 2005;84:115-128.
15. Pagnoux C, Seror R, Henegar C, et al. Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database. Arthritis Rheum 2010;62:616-626.
16. Sergent JS, Lockshin MD, Christian CL, Gocke DJ. Vasculitis with hepatitis B antigenemia: long-term observation in nine patients. Medicine (Baltimore) 1976;55:1-18.
17. Darras-Joly C, Lortholary O, Cohen P, Brauner M, Guillevin L. Regressing microaneurysms in 5 cases of hepatitis B virus related polyarteritis nodosa. J Rheumatol 1995;22:876-880.
18. Guillevin L, Merrouche Y, Gayraud M, et al. Périartérite noueuse du au virus de l'hépatite B. Détermination d'une nouvelle stratégie thérapeutique: 13 cas. Presse Med 1988;17:1522-1526.
19. Guillevin L, Lhote F, Leon A, Fauvelle F, Vivitski L, Trepo C. Treatment of polyarteritis nodosa related to hepatitis B virus with short term steroid therapy associated with antiviral agents and plasma exchanges: a prospective trial in 33 patients. J Rheumatol 1993;20:289-298.
20. Trepo C, Ouzan D, Delmont J, Tremisi J. Superiorité d'un nouveau traitement étiopathogénique curateur des périarter- ites noueuses induites par le virus de l'hepatite B grâce a l'association corticothérapie brève, vidarabine, échanges plasmatiques. Presse Med 1988;17:1527-1531.
21. Guillevin L, Jarrousse B, Lok C, et al. Longterm followup after treatment of polyarteritis nodosa and Churg-Strauss angiitis with comparison of steroids, plasma exchange and cyclophosphamide to steroids and plasma exchange. A prospective randomized trial of 71 patients. The Cooperative Study Group for Polyarteritis Nodosa. J Rheumatol 1991;18:567-574.
22. Guillevin L, Lhote F, Sauvaget F, et al. Treatment of polyarteritis nodosa related to hepatitis B virus with interferonalpha and plasma exchanges. Ann Rheum Dis 1994;53:334-337.
23. Simsek H, Telatar H. Successful treatment of hepatitis B virus- associated polyarteritis nodosa by interferon alpha alone. J Clin Gastroenterol 1995;20:263-265.
24. Kruger M, Boker KH, Zeidler H, Manns MP. Treatment of hepatitis B-related polyarteritis nodosa with famciclovir and interferon alfa-2b. J Hepatol 1997;26:935-939.
25. Auguet T, Barragan P, Ramirez R, Quer JC, Sirvent JJ, Richart C. Lamivudine in the treatment of hepatitis B virus- related polyarteritis nodosa. J Clin Rheumatol 2007;13:298-299.
26. Guillevin L, Mahr A, Cohen P, et al. Short-term corticosteroids then lamivudine and plasma exchanges to treat hepatitis B virus-related polyarteritis nodosa. Arthritis Rheum 2004;51:482-487.
27. Erhardt A, Sagir A, Guillevin L, Neuen-Jacob E, Haussinger D. Successful treatment of hepatitis B virus associated polyarteritis nodosa with a combination of prednisolone, alphainterferon and lamivudine. J Hepatol 2000;33:677-683.
28. Wicki J, Olivieri J, Pizzolato G, et al. Successful treatment of polyarteritis nodosa related to hepatitis B virus with a combination of lamivudine and interferon alpha. Rheumatology (Oxford) 1999;38:183-185.
29. Cohen L, Guillevin L, Meyrier A, Bironne P, Bletry O, Godeau P. L' hypertension arterielle maligne de la periarterite noueuse. Incidence, particularites clinicobiologiques et pronostic a partir d'une serie de 165 cas. Arch Mal Coeur Vaiss 1986;79:773-778.
30. Guillevin L, Lhote F, Gayraud M, et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore) 1996;75:17-28.
31. Guillevin L, Pagnoux C, Seror R, Mahr A, Mouthon L, Le Toumelin P. The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine (Baltimore) 2011;90:19-27.
32. Hachulla E, Bourdon F, Taieb S, et al. Embolization of two bleeding aneurysms with platinum coils in a patient with polyarteritis nodosa. J Rheumatol 1993;20:158-161.
33. San A, Aydin NE, Akcay G, Selcuk Y, Okyar G. Spontaneous bilateral rupture of kidneys in a patient with polyarteritis nodosa. A case report. Scand J Urol Nephrol 1990;24:319-321.
34. Mouthon L, Deblois P, Sauvaget F, Meyrier A, Callard P, Guillevin L. Hepatitis B virus-related polyarteritis nodosa and membranous nephropathy. Am J Nephrol 1995;15:266-269.
35. Combes B, Shorey J, Barrera A, et al. Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane. Lancet 1971;2:234-237.
36. Cacoub P, Terrier B. Hepatitis B-related autoimmune manifestation. Rheum Dis Clin N Am 2009;35:125-137.
37. Khaira A, Upadhyay BK, Sharma A, et al. Hepatitis B virus associated focal and segmental glomerular sclerosis: report of two cases and review of literature. Clin Exp Nephrol 2009;13:373-377.
38. Chan TM. Hepatitis B and renal disease. Curr Hepatitis Rep 2010;9:99-105.
39. Chen L, Wu C, Fan X, et al. Replication and infectivity of hepatitis B virus in HBV-related glomerulonephritis. Int J Infect Dis 2009;13:394-398.
40. Kusakabe A, Tanaka Y, Kurbanov F, et al. Virological features of hepatitis B virus-associated nephropathy in Japan. J Med Virol 2007;79:1305-1311.
41. Gilbert RD, Wiggelinkhuizen J. The clinical course of hepatitis B virus-associated nephropathy. Pediatr Nephrol 1994;8:11-14.
42. Lai KN, Li PK, Lui SF, et al. Membranous nephropathy related to hepatitis B virus in adults. N Engl J Med 1991;324:1457-1463.
43. Chung DR, Yang WS, Kim SB, et al. Treatment of hepatitis B virus associated glomerulonephritis with recombinant human alpha interferon. Am J Nephrol 1997;17:112-117.
44. Okuse C, Yotsuyanagi H, Yamada N, et al. Successful treatment of hepatitis B virus-associated membranous nephropathy with lamivudine. Clin Nephrol 2006;65:53-56.
45. Tang S, Lai FM, Lui YH, et al. Lamivudine in hepatitis B-associated membranous nephropathy. Kidney Int 2005;68:1750-1758.
46. Lin CY. Treatment of hepatitis B virus-associated membranous nephropathy with recombinant alpha-interferon. Kidney Int 1995;47:225-230.
47. Chan MK, Chan KW, Chan PCK, Fang GX, Cheng IKP. Adult- onset mesangiocapillary glomerulonephritis: a disease with a poor prognosis. QJM 1989;72:599-607.
48. Conjeevaram HS, Hoofnagle JH, Austin HA, Park Y, Fried MW, Bisceglie AMD. Long-term outcome of hepatitis B virus-related glomerulonephritis after therapy with interferon alfa. Gastroenterology 1995;109:540-546.
49. Fabrizi F, Dixit V, Martin P Meta-analysis: anti-viral therapy of hepatitis B virus associated glomerulonephritis. Aliment Pharmacol Ther 2006;24:781-788.
50. Gianotti F. Papular acrodermatitis of childhood: an Australia antigen disease.Arch Dis Child 1973;48:794-799.
51. De Gaspari G, Bardare M, Costantino D. AU antigen in Crosti- Gianotti acrodermatitis. Lancet 1970;1:1116-1167.
52. Konno M, Kikuta H, Ishikawa N, et al. A possible association between hepatitis-B antigen-negative infantile papular acrodermatitis and Epstein-Barr virus infection. J Pediatr 1982;101:222-224.
53. Dienstag JL, Rhodes AR, Bhan AK, et al. Urticaria associated with acute viral hepatitis type B: studies of pathogenesis. Ann Intern Med 1978;89:34-40.
54. Neumann HA, Berretty PJ, Folmer SC, et al. Hepatitis B surface antigen deposition in the blood vessel walls of urticarial lesions in acute hepatitis B. Br J Dermatol 1981;104:383-388.
55. Gruppo Italiano Studi Epidemiologici in Dermatologia (GISED). Lichen planus and liver diseases: a multicentre case- control study. Br Med J 1990;300:227-230.
56. Bokor-Bratic M. Lack of evidence of hepatic disease in patients with oral lichen planus in Serbia. Oral Dis 2004;10:283-286.
57. Franceschi S, Lise M, Trépo C, et al. Infection with hepatitis B and C viruses and risk of lymphoid malignancies in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Epidemiol Biomarkers Prev 2011;20:208-214 [Epub 2010/11/23].
58. Yood MU, Quesenberry CP Jr, Guo D, et al. Incidence of non- Hodgkin's lymphoma among individuals with chronic hepatitis B virus infection. Hepatology 2007;46:107-112.
59. Ray G, Ghosh B, Bhattacharyya R. Acute hepatitis B presenting as Guillain-Barré syndrome. Indian J Gastroenterol 2003;22:228.
60. Tsukada N, Koh CS, Inoue A, et al. Demyelinating neuropathy associated with hepatitis B virus infection. Detection of immune complexes composed of hepatitis B virus surface antigen. J Neurol Sci 1987;77:203-216.
61. Grob PJ, Martenet AC, Witmer R. Nonspecific immune parameters and hepatitis B antigens in patients with uveitis. Mod Probl Ophthalmol 1976;16:254-258.
62. Murray PI, Waite J, Rahi AH, et al. Acute anterior uveitis and hepatitis B virus infection. Br J Ophthalmol 1984;68:595-597.
63. Cacoub P, Saadoun D, Bourlière M, et al. Hepatitis B virus genotypes and extrahepatic manifestations. J Hepatol 2005;43:764-770.